Zynex Inc
NASDAQ:ZYXI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.19
13.74
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ZYXI stock under the Base Case scenario is 16.29 USD. Compared to the current market price of 8.26 USD, Zynex Inc is Undervalued by 49%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Zynex Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ZYXI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Zynex Inc
Balance Sheet Decomposition
Zynex Inc
Current Assets | 78.4m |
Cash & Short-Term Investments | 37.6m |
Receivables | 21.6m |
Other Current Assets | 19.1m |
Non-Current Assets | 47.7m |
PP&E | 14.9m |
Intangibles | 27.9m |
Other Non-Current Assets | 4.9m |
Current Liabilities | 19.9m |
Accounts Payable | 9.3m |
Accrued Liabilities | 9.9m |
Other Current Liabilities | 674k |
Non-Current Liabilities | 70.4m |
Long-Term Debt | 59.2m |
Other Non-Current Liabilities | 11.2m |
Earnings Waterfall
Zynex Inc
Revenue
|
193.7m
USD
|
Cost of Revenue
|
-38.4m
USD
|
Gross Profit
|
155.3m
USD
|
Operating Expenses
|
-146.5m
USD
|
Operating Income
|
8.9m
USD
|
Other Expenses
|
-4m
USD
|
Net Income
|
4.8m
USD
|
Free Cash Flow Analysis
Zynex Inc
USD | |
Free Cash Flow | USD |
ZYXI Profitability Score
Profitability Due Diligence
Zynex Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Zynex Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
ZYXI Solvency Score
Solvency Due Diligence
Zynex Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Zynex Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZYXI Price Targets Summary
Zynex Inc
According to Wall Street analysts, the average 1-year price target for ZYXI is 14.96 USD with a low forecast of 11.11 USD and a high forecast of 17.85 USD.
Dividends
Current shareholder yield for ZYXI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ZYXI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 774 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS). The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, and E-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream, Knee Braces and LSO Back Braces, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. CM-1500 is a Zynex fluid monitoring system.
Contact
IPO
Employees
Officers
The intrinsic value of one ZYXI stock under the Base Case scenario is 16.29 USD.
Compared to the current market price of 8.26 USD, Zynex Inc is Undervalued by 49%.